Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: OssDsign AB (publ)

Market Cap 458M 48.73M 42.09M 38.79M 36.31M 68.04M 4.63B 69.09M 179M 2.25B 183M 179M 7.81B P/E Ratio 2026 *
-8.87x
P/E Ratio 2027 * -12.7x
Enterprise Value 341M 36.28M 31.34M 28.88M 27.03M 50.66M 3.45B 51.44M 133M 1.68B 136M 133M 5.81B EV / Sales 2026 *
2.04x
EV / Sales 2027 * 1.66x
Free-Float
67.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2025-12-31
Director of Finance/CFO 63 2019-12-31
Chief Tech/Sci/R&D Officer 47 2021-12-31
Director TitleAgeSince
Chairman 66 2016-04-19
Director/Board Member 60 2021-12-31
Director/Board Member 61 2024-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 48.73M
+2.15%+2.14%-17.25%+6.35% 120B
0.00%-0.40%+4.80%-9.31% 12.9B
+2.05%+1.45%+29.93%+89.66% 7.44B
+1.87%-4.66%-46.88%-70.47% 4.2B
+2.06%+4.10%+11.98%+33.22% 2.55B
+5.46%+10.04%-15.76%-14.88% 1.8B
+1.67%-5.73%+5.08%-11.03% 1.66B
-8.89%-10.79%+152.96%+121.29% 1.37B
Average -3.30%+0.88%+15.61%+18.10% 18.95B
Weighted average by Cap. +1.87%+1.76%-11.59%+8.02%

Financials

2026 *2027 *
Net sales 168M 17.83M 15.4M 14.19M 13.28M 24.89M 1.69B 25.27M 65.32M 825M 66.9M 65.48M 2.86B 238M 25.36M 21.9M 20.18M 18.89M 35.41M 2.41B 35.96M 92.92M 1.17B 95.18M 93.15M 4.06B
Net income -51.27M -5.46M -4.71M -4.34M -4.06M -7.62M -519M -7.73M -19.99M -252M -20.47M -20.04M -874M -35.73M -3.8M -3.28M -3.03M -2.83M -5.31M -361M -5.39M -13.93M -176M -14.27M -13.97M -609M
Net Debt -117M -12.45M -10.75M -9.91M -9.28M -17.38M -1.18B -17.65M -45.62M -576M -46.72M -45.73M -1.99B -63M -6.7M -5.79M -5.34M -4.99M -9.36M -637M -9.5M -24.56M -310M -25.16M -24.62M -1.07B
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
35
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!